COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation

Area of Science:

• Oncology
• Molecular Biology
• Extracellular Matrix Research

Background:

• Epidermal Growth Factor Receptor (EGFR) activation is a key driver in non-small cell lung cancer (NSCLC) progression.
• Identifying molecular mechanisms that promote EGFR activation is crucial for understanding and treating NSCLC.

Purpose of the Study:

• To investigate the role of collagen type VIII alpha 1 chain (COL8A1) in NSCLC pathogenesis.
• To elucidate the relationship between COL8A1, interferon-induced proteins (IFIT1, IFIT3), and EGFR activation in NSCLC.

Main Methods:

• Investigated COL8A1 expression in NSCLC cells and patient samples.
• Utilized gene knockdown and overexpression techniques to assess COL8A1 function.
• Analyzed cell proliferation, apoptosis, migration, and cell cycle progression.
• Measured interferon response signaling and the expression of IFIT1 and IFIT3.
• Evaluated EGFR activation in vitro and in vivo.

Main Results:

• COL8A1 was overexpressed in NSCLC and its knockdown suppressed tumor cell growth, migration, and induced apoptosis.
• COL8A1 overexpression enhanced proliferation and inhibited apoptosis in NSCLC cells.
• COL8A1 depletion reduced interferon response signaling, downregulating IFIT1 and IFIT3.
• COL8A1 upregulated IFIT1 and IFIT3, mediating EGFR activation.
• A positive correlation was observed between COL8A1, IFIT1, IFIT3 expression, and EGFR activity in NSCLC patients.

Conclusions:

• COL8A1 promotes NSCLC proliferation and invasion by activating EGFR signaling.
• The mechanism involves the upregulation of IFIT1 and IFIT3 expression.
• COL8A1 represents a potential therapeutic target for NSCLC.